Tag: Rare cancer cell therapy

Home / Rare cancer cell therapy

Categories

Orphan drug designation is given by FDA to CART T-Cell Therapy A2B530 for the treatment of colorectal cancer

In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (C...
rare-cancer-cell-therapy

Scan the code